Contact : +61 413 227 332

All posts by LiVac Team

Springboard Enterprises publishes blog by Livac CEO

Livac Pty Ltd CEO, Dr Anabela Correia, shares her insights into working with distribution partners to achieve success and grow into new markets.

The path to technology commercialisation is one that is well-documented and well-worn: unmet need leads to an idea, proof of concept built, asset protected, business plan developed, funding obtained, strategic partnerships formed, and the branded product is launched into market. These days anyone with the right idea and the right guidance can become an entrepreneur.

Read More

Mergermarket interviews Livac CEO, Dr Anabela Correia

Livac is actively seeking AUD $6m to support US market entry

Article by Louise Weihart – mergermarket, Sept 2019

Livac, a privately held Melbourne-based Australian developer of devices to support minimally invasive surgery (MIS), is actively seeking AUD 6m (USD 4m) from new investors to support US market entry, said CEO Anabela Correira.

Read More

LiVac achieves key milestone in US marketing entry strategy

Livac Pty Ltd, an Australian medical device company, after having completed all necessary regulatory requirements of the US Food and Drug Administration, can now proceed with supply of their organ retraction system “the LiVac™ Retractor System” in the US market.

Read More

Livac Shareholder Update

First use in robotic bariatric procedure

The first use of the LiVac™ Retractor in a robotic bariatric procedure was recently conducted in Melbourne. The LiVac™ Retractor was used for the first time with a da Vinci® robot and retracted the liver throughout the duration of the Laparoscopic Sleeve Gastrectomy case. The surgeon involved went on to apply for the LiVac™ to be listed and commercially available at his hospital.

Read More